@article{APM32344,
author = {Rui Huang and Xiuxia Li and Shihong Xu and Dingpeng Li and Peijing Yan and Bo Liu and Xingwen Xie and Kehu Yang},
title = {Acupoint injection treatment for primary osteoporosis: a systematic review and meta-analysis of randomized controlled trials},
journal = {Annals of Palliative Medicine},
volume = {8},
number = {5},
year = {2019},
keywords = {},
abstract = {Background: Acupoint injection has currently received increasing attention as a treatment for primary osteoporosis (POP), This study aimed to evaluate the efficacy and safety of acupoint injection as a clinical treatment for POP.
Methods: Randomized controlled trials (RCTs) of acupoint injection compared with conventional non-acupoint injection for POP were identified in searches of seven databases from their inception to March 2019. All data were assessed and extracted by two authors independently. The risk of bias assessment recommended by the Cochrane Collaboration was used to assess the quality of the selected studies. RevMan 5.3 was used to conduct meta-analysis for the efficacy and safety of acupoint injection.
Results: Five trials with 337 patients (aged 45–86 years) with bone mineral density (BMD) ≤2 SD were included in our meta-analysis. The results showed that, compared with conventional intramuscular injection, acupoint injection significantly increased the BMD [mean difference (MD) =0.02; 95% CI, 0.01 to 0.03, P},
issn = {2224-5839}, url = {https://apm.amegroups.org/article/view/32344}
}